Pharmocann Global (XTAE:PMCN-M) Debt-to-Asset : 0.06 (As of Dec. 2023)

Pharmocann Global Debt-to-Asset Chart

Pharmocann Global Annual Data
	Trend	Dec09	Dec10	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Asset		Get a 7-Day Free Trial					0.05	0.05	0.09	0.14	0.06

Pharmocann Global Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.13	0.15	0.14	0.08	0.06

Competitive Comparison of Pharmocann Global's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmocann Global's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmocann Global's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmocann Global's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharmocann Global's Debt-to-Asset falls into.

Pharmocann Global Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Pharmocann Global's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Pharmocann Global's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmocann Global  (XTAE:PMCN-M) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Pharmocann Global Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global (XTAE:PMCN-M) Business Description